Research Papers

25 of 1103 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Enhancing Interoperability and Harmonisation of Nuclear Medicine Image Data and Associated Clinical Data.
Fuchs T; Kaiser L; Müller D; Papp L; Fischer R; Tran-Gia J.
Nuklearmedizin (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Nearly double the patients and dramatic changes over 14 years of UK MRT: Internal Dosimetry Users Group survey results …
Rojas B; McGowan DR; Gear J; Smith AL; Scott C; Craig AJ; Scuffham J; Towey D; Aldridge M; Tipping J.
Nucl Med Commun (Unknown)
Published: 2023
1/6 Transparent
BNMS UK PET standards.
Cook GJR; Dickson J; Chicklore S; Dempsey M; Ferreira A; MacKewn J; Meadows A; Testenera G; Wan S.
Nucl Med Commun (Unknown)
Published: 2023
2/6 Transparent
Artificial Intelligence-Driven Single-Shot PET Image Artifact Detection and Disentanglement: Toward Routine Clinical Im…
Shiri I; Salimi Y; Hervier E; Pezzoni A; Sanaat A; Mostafaei S; Rahmim A; Mainta I; Zaidi H.
Clin Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Mono- and multimeric PSMA-targeting small molecule-thorium-227 conjugates for optimized efficacy and biodistribution in…
Böhnke N; Indrevoll B; Hammer S; Papple A; Kristian A; Briem H; Celik A; Mumberg D; Cuthbertson A; Zitzmann-Kolbe S.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
High efficacy of particle beam therapies against tumors under hypoxia and prediction of the early stage treatment effec…
Makino A; Kume K; Mori T; Tsujikawa T; Asai T; Okazawa H; Kiyono Y.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Cardiac [<sup>99m</sup>Tc]Tc-hydroxydiphosphonate uptake on bone scintigraphy in patients with hereditary transthyretin…
Tingen HSA; Tubben A; Bijzet J; van den Berg MP; van der Meer P; Houwerzijl EJ; Muntinghe FLH; van der Zwaag PA; Glaudemans AWJM; Oerlemans MIFJ; Knackstedt C; Michels M; Hirsch A; Hazenberg BPC; Slart RHJA; Nienhuis HLA.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
p53 stabilisation potentiates [<sup>177</sup>Lu]Lu-DOTATATE treatment in neuroblastoma xenografts.
Berglund H; Salomonsson SL; Mohajershojai T; Gago FJF; Lane DP; Nestor M.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Fast method of determining the ambient dose equivalent at a depth of 10 mm of gamma-neutron fields based on recombinati…
Kuć M.
Radiat Prot Dosimetry (Unknown)
Published: 2023
1/6 Transparent
Integrating TSPO PET imaging and transcriptomics to unveil the role of neuroinflammation and amyloid-β deposition in Al…
Zhang M; Qian XH; Hu J; Zhang Y; Lin X; Hai W; Shi K; Jiang X; Li Y; Tang HD; Li B.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
4/6 Transparent
Data Funding Declared
Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer.
Meyer C; Stuparu A; Lueckerath K; Calais J; Czernin J; Slavik R; Dahlbom M.
J Nucl Med (Unknown)
Published: 2023
2/6 Transparent
Proliferation and apoptosis after whole-body irradiation: longitudinal PET study in a mouse model.
Meindl M; Bläske A; Steiger K; Lindner S; Lindheimer F; Lauber K; Brix N; von Ungern-Sternberg B; Oos R; Palumbo G; Böning G; Schüle S; Majewski M; Port M; Ziegler S; Bartenstein P.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Clinical Characterization of [<sup>18</sup>F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modelin…
Constantinescu CC; Brown T; Wang S; Yin W; Barret O; Jennings D; Tauscher J.
J Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Long-axial field-of-view PET/CT for the assessment of inflammation in calcified coronary artery plaques with [<sup>68</…
Mingels C; Sari H; Gözlügöl N; Bregenzer C; Knappe L; Krieger K; Afshar-Oromieh A; Pyka T; Nardo L; Gräni C; Alberts I; Rominger A; Caobelli F.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-18 FDG activities in…
Tran-Gia J; Eberlein U; Lassmann M; Mauz-Körholz C; Körholz D; Zuccetta P; Bar-Sever Z; Rosner U; Georgi TW; Sabri O; Kluge R; Piccardo A; Kurch L.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
The tyrosine kinase inhibitor nintedanib enhances the efficacy of 90 Y-labeled B5209B radioimmunotherapy targeting ROBO…
Fujiwara K; Tsuji AB; Sudo H; Sugyo A; Hamakubo T; Higashi T.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in advanced somatostatin r…
Wild D; Grønbæk H; Navalkissoor S; Haug A; Nicolas GP; Pais B; Ansquer C; Beauregard JM; McEwan A; Lassmann M; Pennestri D; Volteau M; Lenzo NP; Hicks RJ.
Eur J Nucl Med Mol Imaging (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Fluorescence in situ hybridisation for interphase chromosomal aberration-based biological dosimetry.
Meher PK; Lundholm L; Wojcik A.
Radiat Prot Dosimetry (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Monte Carlo modelling of experimental setup used for biodosimetry intercomparison.
Gunasekara D; Wilkins R; Tessier F; Beaton-Green L.
Radiat Prot Dosimetry (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Development of high-throughput systems for biodosimetry.
Wilkins RC; Beaton-Green LA.
Radiat Prot Dosimetry (Unknown)
Published: 2023
1/6 Transparent
Rabbit systemic glucose metabolism map by total-body dynamic PET/CT technology.
Wang H; Xie X; Duan Y; Chai L; Li K; Qiu J; Cheng Z.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Practice recommendation for measuring washout rates in <sup>123</sup>I-BMIPP fatty acid images.
Nakajima K; Miyauchi H; Hirano KI; Fujimoto S; Kawahito M; Iimori T; Kudo T.
Ann Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive value of SUVmax in visceral pleural invasive lung adenocarcinoma with different diameters.
Sun X; Chang C; Xie C; Zhu J; Ni X; Xie W; Wang Y.
Nucl Med Commun (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Predictive IDH Genotyping Based on the Evaluation of Spatial Metabolic Heterogeneity by Compartmental Uptake Characteri…
Lohmeier J; Radbruch H; Brenner W; Hamm B; Tietze A; Makowski MR.
J Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
New Developments in Myeloma Treatment and Response Assessment.
Kraeber-Bodéré F; Jamet B; Bezzi D; Zamagni E; Moreau P; Nanni C.
J Nucl Med (Unknown)
Published: 2023
3/6 Transparent
Funding Declared